Genie Energy Announces Second Quarter 2025 Results GlobeNewswire August 07, 2025 Newark, NJ, Aug. 07, 2025 (GLOBE NEWSWIRE) — Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the second quarter of 2025. Michael Stein, Chief Executive Officer of Genie Energy, commented: “Our second quarter yielded […]

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program Conference Call Scheduled for 8:30 AM EDT Today, August 7, 2025 GlobeNewswire August 07, 2025 SEATTLE and VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global

Kelly Reports Second-Quarter 2025 Earnings GlobeNewswire August 07, 2025 TROY, Mich., Aug. 07, 2025 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced results for the second quarter of 2025. Q2 revenue of $1.1 billion, up 4.2% year-over-year reflecting previously disclosed acquisitions, and down 3.3% on an organic basis

Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 07, 2025 – Registrational cohort enrollment in RESET-Myositis(TM) trial on track to start in 2H25 with anticipated 2027 BLA submission for rese-cel in myositis – – Five disease-specific cohorts fully enrolled in the RESET(TM) clinical development program from over 70 clinical

Clarence Square Revitalization Activates Key Pedestrian Corridor and Green Space in Downtown Toronto GlobeNewswire August 07, 2025 Toronto, ON, Aug. 07, 2025 (GLOBE NEWSWIRE) — The Toronto Downtown West BIA (TDWBIA), in partnership with the City of Toronto, is pleased to announce initial improvements to Clarence Square Park – a widely-accessed green space in the

Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025 GlobeNewswire August 07, 2025 PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the treatment of cancer, today announced

Kelly Announces Selection of Chris Layden as President and Chief Executive Officer GlobeNewswire August 07, 2025 TROY, Mich., Aug. 07, 2025 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced that Chris Layden has been selected to serve as president and chief executive officer, effective September 2, 2025.

Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress GlobeNewswire August 07, 2025 Enrollment in the global Phase 3 MAGNITUDE trial of nexiguran ziclumeran (nex-z) in ATTR with cardiomyopathy (ATTR-CM) continues to track ahead of projections; Tracking to enroll at least 650 patients cumulatively by year-end Expanding total enrollment of the

Knight Therapeutics Reports Second Quarter 2025 Results GlobeNewswire August 07, 2025 Achieved record-high quarterly revenues since inceptionIncreased 2025 financial guidance MONTREAL, Aug. 07, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its second quarter ended June 30, 2025. All

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer GlobeNewswire August 07, 2025 Joseph Hulihan, MD, MSHP, brings substantial clinical development experience advancing novel therapies for TSC-related epilepsy and other neurological disorders Clinical study for simufilam in TSC-related epilepsy expected to begin in H1 2026 AUSTIN, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) — Cassava